Biotherapeutics are famously difficult to model, with many variables to account for and manage. With a focus on the potential for in-silico methods to decrease the drug's time to marketability, Actimo Labs was born as a passion project by four students based in Australia.

Our vision is simple: we believe that life-changing drugs don't need to spend all that time in the development pipeline with a constant risk of failure. You worry about the impact, let us take care of the rest.